Ain Holdings Inc. (TYO:9627)
Japan
· Delayed Price · Currency is JPY 5,284.00
+45.00 (0.86%)
Jun 12, 2025, 3:30 PM JST
Ain Holdings Revenue
In the fiscal year ending April 30, 2025, Ain Holdings had annual revenue of 456.80B JPY with 14.25% growth. Ain Holdings had revenue of 119.97B in the quarter ending April 30, 2025, with 15.95% growth.
Revenue
456.80B
Revenue Growth
+14.25%
P/S Ratio
0.41
Revenue / Employee
39.81M
Employees
11,474
Market Cap
185.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 456.80B | 56.98B | 14.25% |
| Apr 30, 2024 | 399.82B | 41.08B | 11.45% |
| Apr 30, 2023 | 358.74B | 42.50B | 13.44% |
| Apr 30, 2022 | 316.25B | 18.94B | 6.37% |
| Apr 30, 2021 | 297.31B | 4.69B | 1.60% |
| Apr 30, 2020 | Pro | Pro | Pro |
| Apr 30, 2019 | Pro | Pro | Pro |
| Apr 30, 2018 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |